3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Leukemia
48
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
Lymphoma
40
Myelodysplastic Syndromes
30
Lymphoma, Non-Hodgkin
29
Lymphoma, Large B-Cell, Diffuse
27
Lymphoma, Follicular
27
Leukemia, Myeloid, Acute
26
Leukemia, Myeloid, Chronic-Phase
25
Leukemia, Lymphocytic, Chronic, B-Cell
24
Burkitt Lymphoma
24
Leukemia, Myeloid, Accelerated Phase
23
Lymphoma, Large-Cell, Immunoblastic
22
Multiple Myeloma
20
Hodgkin Disease
20
Myeloproliferative Disorders
19
Lymphoma, Mantle-Cell
18
Lymphoma, B-Cell, Marginal Zone
18
Graft vs Host Disease
18
Blast Crisis
18
Neoplasms, Plasma Cell
17
Leukemia, Myelomonocytic, Chronic
16
Dendritic Cell Sarcoma, Interdigitating
15
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
14
Congenital Abnormalities
14
Recurrence
13
Anemia, Refractory, with Excess of Blasts
13
Primary Myelofibrosis
12
Myelodysplastic-Myeloproliferative Diseases
12
Lymphoma, T-Cell, Cutaneous
10
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Heart Arrest, Induced
1
Haloperidol
1
Fosfomycin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Bosentan
1
Aminocaproic Acid
1
Amikacin
1
Alfentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Heart Arrest
×
Methylprednisolone
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled